ClinicalTrials HQ

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

Recruiting · NCT06671054 · Registry updated 2025-10-06
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid ArthritisSkin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritisRecruitingPhase 22025-10-06NCT06671054

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
NBCD A/S2
SynAct Pharma Aps3

11 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Altoona Center for Clinical ResearchDuncansvilleUnited States32
DC-MED Michal Kowalski S.K.SwidnicaPoland1
Diagnostic Consultative Center AleksandrovskaSofiaBulgaria4
IMSP Spitalul Clinic Municipal "Sfanta Treime"ChisinauMoldova1
M2MmedChorzówPoland1
Medical Center Tera MedicoVratsaBulgaria1
Medyczne Centrum HetmańskaPoznanPoland3
Millennium Medical Research LlcMiamiUnited States2
Nouvelle Clinical Research LLCCutler BayUnited States4
Sanos Clinic HerlevHerlevDenmark3
Vita Longa Sp. z o. o.KatowicePoland1